• Skip to main content

Everyday Prevention Evidence

Read prevention guidance with context, numbers, and clear limits.

  • Home
  • Start Here
  • Research
  • Editorial
  • About
  • Contact

Why a Study Protocol and the Published Report May Not Match

posted on September 9, 2026

Updated October 9, 2026

By the Everyday Prevention Evidence Team

What Does It Mean When a Study Protocol Doesn’t Match the Published Report?

A study protocol is the plan a research team registers on a public database like ClinicalTrials.gov before or during a trial; the published report is the paper that comes out afterward describing what actually happened. Some differences between the two are normal — outcomes can shift, sample sizes can change, and timelines can move for ordinary reasons.

Maybe you found a trial’s registry page and then found the published paper about that same trial, and something doesn’t line up — the outcomes listed are different, the participant count changed, or a measurement that was supposed to be the main focus barely gets mentioned. Now you’re wondering whether that means something went wrong. Sometimes it does. Often it doesn’t. This guide shows you how to compare a study protocol against its published report, spot the changes worth asking a question about, and avoid treating every difference as proof of a problem.

A Study Protocol and a Published Report Are Two Different Documents With Two Different Jobs

A protocol is the plan a research team registers before or soon after a study begins. On a registry, it typically lists the planned design, the number of participants the team hopes to enroll, the treatments or interventions being compared, and the outcomes the team intends to measure — usually split into a primary outcome (the main result the study is designed to answer) and one or more secondary outcomes (other results collected along the way). For background on how we evaluate sources like study registries, see our How We Research page.

A published report is the article that appears later in a medical or scientific journal, describing what the researchers actually did and found. It’s written after the study is complete, often years after the protocol was first registered, and it goes through its own editorial and peer-review process.

Registries such as ClinicalTrials.gov are built to hold structured, plan-stage information — the study’s registered data elements — and, importantly, they preserve that information over time rather than overwriting it. When a study record is updated, the platform’s public archive keeps prior versions viewable, so a reader can compare what was registered at one point against what’s registered later, or against the final published report.

How to Map a Study From Registration to Publication

Before deciding whether a difference between a protocol and its report is meaningful, place each document into this sequence. It helps you see where a discrepancy actually entered the picture.

  1. Registration: The protocol is entered into a public registry, usually before enrollment begins. This is the “plan” stage.
  2. Conduct: The trial runs. Real-world issues — slow enrollment, safety findings, funding changes — sometimes require the team to adjust the plan.
  3. Record updates: If the team changes the design or outcomes, a responsible registry update reflects that change and keeps the earlier version archived, not erased.
  4. Publication: The final report is written and submitted to a journal, describing what was actually done and found, plus reasons for any changes from the original plan.
  5. Your comparison: You are looking at the registry record (possibly several versions of it) alongside the published report, checking for consistency.

A difference that shows up as a documented, dated change between steps 2 and 3 — visible in the registry’s own archive — is a very different situation than a difference that appears only in step 4, with no earlier trace anywhere in the registry.

Which Protocol-to-Report Differences Are Worth Asking About?

Use these questions to sort a difference into “probably routine” or “worth a closer look.”

Did the outcome change, and was the change explained?

Reporting guidelines for clinical trials, including the widely used CONSORT 2010 Statement, exist specifically because outcomes sometimes shift between registration and publication. CONSORT asks authors to state clearly which outcomes were defined before the trial started and to document and justify any changes made to the trial’s design or outcomes after it began. A published report that mentions the change and gives a reason — for example, a safety concern, a data quality issue, or new evidence from another study — is doing what good reporting practice asks. A report that simply presents a different primary outcome with no mention of the original one is a bigger yellow flag.

Is the change visible in the registry’s own history, or does it only appear in the paper?

Because registries preserve earlier versions of a study record, you can often check whether a design or outcome change was recorded around the time it happened, rather than only showing up after the results were known. A change documented during the trial is more reassuring than one that surfaces for the first time in the final publication.

Did the primary outcome quietly become a secondary outcome, or disappear?

This is one of the patterns transparency advocates watch for most closely: a trial is registered with one main outcome, that outcome doesn’t show a favorable result, and the published paper instead emphasizes a different measurement as if it were the focus all along. Comparing the originally registered primary outcome to what the abstract and conclusion of the published paper emphasize is one of the most useful checks a reader can do.

Do the participant numbers match, and is any drop explained?

The number of people enrolled, and the number whose data was actually analyzed, can differ from what was planned. A published report should account for participants who dropped out or were excluded. An unexplained gap between the planned number and the analyzed number is worth noting, even if it isn’t necessarily a sign of misconduct.

Does Every Protocol Change Mean a Study Can’t Be Trusted?

No. Trials are amended for many ordinary reasons: slow recruitment, a safety signal that changes the design mid-study, updated guidance from an ethics board, or a genuine improvement to the measurement approach. What matters is whether the change is disclosed and explained, not whether a change happened at all. A study that never once needed a documented adjustment between protocol and report is less common than you might think. Read our Start Here guide if you’re new to reading primary research and want the basics first.

A Printable Checklist for Comparing a Study Protocol to Its Published Report

Print or copy this list when you sit down to compare a registry entry with a published report.

  • Find the study’s registry page and note the registration date and the version you’re viewing.
  • Check the registry’s archive or history feature for earlier versions of the same record, if available.
  • Write down the originally registered primary outcome and any secondary outcomes.
  • Read the published report’s abstract and results section. Note which outcome is emphasized as the main finding.
  • Compare the two outcome lists. Are they the same? If not, does the report explain why?
  • Compare the planned number of participants to the number actually analyzed. Is any difference explained?
  • Note the date of any registry update relative to the trial’s timeline — was it made during the study or only after results were known?
  • If something is unexplained, write it down as a specific question rather than a conclusion. You can bring that question to a clinician, a librarian, or the study’s listed contact.

What This Comparison Can and Can’t Tell You

This kind of comparison can help you become a more careful reader of research and can surface specific, answerable questions. It cannot tell you, on its own, whether a study’s results are reliable, whether a treatment works, or whether a change was made in good faith. Evaluating a discrepancy fully often requires looking at supplementary materials, contacting the study authors, or consulting someone trained in research methods. Treat an unexplained protocol-to-report difference as a reason to ask a more specific question, not as proof of a problem.

Common Questions About Comparing Study Protocols and Published Reports

Where do I find a study’s original protocol?

Public registries like ClinicalTrials.gov are the standard place to look. Search for the trial by name, condition, or the study’s registration number if you have it from the published paper’s methods section.

Can a registry entry be edited after a study starts?

Yes. Research teams can update a study’s registry record as the trial progresses. Reputable registries preserve the earlier version rather than deleting it, which is what makes a before-and-after comparison possible.

Is it normal for a published paper to have a different sample size than the protocol listed?

Some change is common, since real trials deal with dropouts, exclusions, and enrollment challenges. What to look for is whether the published report explains the gap between the planned and analyzed numbers.

Does a protocol change always mean the researchers were hiding something?

No. Many changes come from legitimate reasons like safety findings or slow recruitment. The disclosure and justification of the change matters more than the fact that a change happened.

Medical and Educational Information Disclaimer

This article is educational information about how to read and compare public clinical trial documents. It is not medical advice, and it does not evaluate, endorse, or discredit any specific study, treatment, or health claim. Everyday Prevention Evidence is an independent editorial publication and is not affiliated with, and does not represent, any clinical trial sponsor, research institution, or the operators of any registry referenced here. If you have questions about a specific treatment or trial result that affects your own care, talk with a qualified healthcare provider.

Sources: ClinicalTrials.gov, Data Element Definitions (clinicaltrials.gov/data-api/about-api/study-data-structure); EQUATOR Network, CONSORT 2010 Statement (equator-network.org/reporting-guidelines/consort).

By Everyday Prevention Evidence Editorial Team. Last updated September 9, 2026.

Related guides

  • How to Tell a Study, Guideline, and Patient Fact Sheet Apart
  • Best Study Methods for Medical Students: What Research Supports
  • Top 5 Study Techniques: A Practical Guide
  • Corrections, Expressions of Concern, and Retractions: What They Mean for a Health Study

Filed Under: study and risk literacy

Reader Interactions

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Everyday Prevention Evidence

Read prevention guidance with context, numbers, and clear limits.

Topics

  • Start Here
  • Reading Study Numbers
  • Study Design and Evidence Strength
  • Checking Sources and Reports
  • Applying Evidence to You

Publication

  • About
  • Editorial Policy
  • Review Process
  • Corrections
  • Independence Notice
  • Contact

Policies

  • Privacy Policy
  • Terms of Use
  • Medical Disclaimer
  • Affiliate Disclosure
  • Accessibility

Everyday Prevention Evidence is an independent editorial publication at UU4VE.org. It is not affiliated with the former physician or vaccination campaign, and UU4VE is not used here as an expansion of that former organization's name.

Questions about the operator of this site: contact@uu4ve.org or the Contact page.

© 2026 Everyday Prevention Evidence